You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HTLV-I Infections

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Evaluation of Patients With HAM/TSP

Recruiting
  • HTLV-I Infection
  • Tropical Spastic Paraparesis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 25, 2023

    Survival of Adult T-cell Leukemia / Lymphoma and Patients

    Recruiting
    • Lymphoproliferation Induced by HTLV-1
    • +2 more
      • Paris, France
        Hôpital Necker Enfants Malades
      Sep 26, 2022

      HTLV-I Infection Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Raltegravir)

      Completed
      • HTLV-I Infection
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 18, 2022

      HTLV-I Infections Trial in Belém (Rehabilitation)

      Completed
      • HTLV-I Infections
      • Rehabilitation
      • Belém, Pará, Brazil
        Universidade da Amazônia
      Aug 11, 2020

      Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

      Recruiting
      • Acute Adult T-Cell Leukemia/Lymphoma
      • +3 more
      • Atlanta, Georgia
      • +13 more
      Jan 26, 2023

      HAM/TSP Trial run by the NINDS (Teriflunomide)

      Recruiting
      • HAM/TSP
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      HTLV-I-associated Myelopathy Trial in London (Zidovudine/lamivudine, Placebos)

      Completed
      • HTLV-I-associated Myelopathy
      • London, United Kingdom
        Imperial College
      Aug 24, 2021

      HTLV I Associated Myelopathy Trial in London (ciclosporin)

      Completed
      Has Results
      • HTLV I Associated Myelopathy
      • London, United Kingdom
        National Centre for Human Retrovirology
      Sep 6, 2021

      Ibd CAncer and seRious Infections in France (I-CARE 2)

      Not yet recruiting
      • IBD
      • +2 more
      • Non-interventional
      • Amiens, France
      • +1 more
      Oct 13, 2023

      T Cell Leukemia, Adult, Leukemia, Adult T-Cell, T Cell Leukemia, HTLV I Associated Trial run by the NCI (Ruxolitinib,

      Completed
      • T Cell Leukemia, Adult
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Jan 26, 2022

      Acute Adult T-Cell Leukemia/Lymphoma, Adult T-Cell Leukemia/Lymphoma, Chronic Adult T-Cell Leukemia/Lymphoma Trial in United

      Completed
      Has Results
      • Acute Adult T-Cell Leukemia/Lymphoma
      • +5 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Baltimore, Maryland
      • +7 more
      Dec 2, 2019

      Anti-interferon Autoantibodies on Viral Load in Severe

      Not yet recruiting
      • Severe Respiratory Infections
      • Serum anti-IFN-I antibodies
      • (no location specified)
      Sep 12, 2022

      Respiferon Project

      Recruiting
      • Respiratory Viral Infection
      • Evaluate the performance of IFN I/III
      • Lyon, Rhone, France
        Infective Agents Institute, Croix rousse Hospital
      Aug 24, 2023

      Urinary Tract Infection Bacterial Trial in United States (Bacteriophage Therapy)

      Active, not recruiting
      • Urinary Tract Infection Bacterial
      • Bacteriophage Therapy
      • Doral, Florida
      • +7 more
      Jan 25, 2023

      Cytomegalovirus Infections Trial in Manchester (SPYVAC01)

      Not yet recruiting
      • Cytomegalovirus Infections
      • SPYVAC01
      • Manchester, United Kingdom
        Medicines Evaluation Unit
      Nov 20, 2023

      Pneumococcal Disease Trial (XJ103 Injection, Placebo)

      Not yet recruiting
      • Pneumococcal Disease
      • XJ103 Injection
      • Placebo
      • (no location specified)
      Sep 6, 2023

      Recurrent Respiratory Papillomatosis, Papillomavirus Infections, Papillomaviridae Trial run by the PGEN Therapeutics, Inc., a

      Recruiting
      • Recurrent Respiratory Papillomatosis
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 5, 2023

      Pneumococcal Infections Trial in Xiangtan (13-Valent Pneumococcal Polysaccharide Conjugate Vaccine)

      Recruiting
      • Pneumococcal Infections
      • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
      • Xiangtan, Hunan, China
        Xiangtan Maternal and Child Health Hospital
      Nov 11, 2022

      Human Papillomavirus Infection Trial in Canberra (Human papillomavirus (HPV) Vaccine, Placebo)

      Not yet recruiting
      • Human Papillomavirus Infection
      • Human papillomavirus (HPV) Vaccine
      • Placebo
      • Canberra, Australia
        Paratus Clinical Research Canberra
      Jan 4, 2023

      Prevent Hospitalizations for Viral Respiratory Infections in

      Not yet recruiting
      • Severe Acute Respiratory Infection (SARI)
      • +2 more
        • Dijon, France
        • +7 more
        Oct 17, 2022

        Airway Obstruction, Respiratory Infection, Mucus; Plug Trial in Badalona, Barcelona, Cartagena (High flow nasal cannula,

        Not yet recruiting
        • Airway Obstruction
        • +2 more
        • High flow nasal cannula
        • nebulized normal saline
        • Badalona, Spain
        • +2 more
        Oct 10, 2023

        Malaria, Malaria,Falciparum, Protozoan Infections Trial in Sheffield (Matrix M with RH5.1)

        Recruiting
        • Malaria
        • +5 more
        • Matrix M with RH5.1
        • Sheffield, United Kingdom
          Sheffield Teaching Hospitals, Royal Hallamshire Hospital
        Nov 14, 2023

        COVID-19 Respiratory Infection, COVID-19 Vaccine Adverse Reaction Trial in Stockholm (DNA vaccine OC-007, Placebo)

        Not yet recruiting
        • COVID-19 Respiratory Infection
        • COVID-19 Vaccine Adverse Reaction
        • DNA vaccine OC-007
        • Placebo
        • Stockholm, Region Stockholm, Sweden
          Phase I Study Unit, Karolinska University Hospital
        Jan 13, 2023

        Diphtheria, Tetanus, Pertussis Trial (DTaP-HepB-IPV-Hib vaccine)

        Not yet recruiting
        • Diphtheria
        • +5 more
        • DTaP-HepB-IPV-Hib vaccine
        • (no location specified)
        Jul 11, 2023

        Pneumococcal Infections, Streptococcal Infections, Bacterial Infections Trial in Anyang (13-Valent Pneumococcal Polysaccharide

        Active, not recruiting
        • Pneumococcal Infections
        • +2 more
        • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine（CRM197,TT）
        • 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine
        • Anyang, Henan, China
          Neihuang Center for Disease Control and Prevention
        Oct 28, 2022